Učitavanje...
Omalizumab-associated eosinophilic granulomatosis with polyangiitis: cause or coincidence?
Omalizumab is an anti-IgE monoclonal antibody used in severe allergic asthma. Herein, we describe a case of eosinophilic granulomatosis with polyangiitis, which manifested 3 months after initiation of omalizumab therapy, while maintenance corticosteroid therapy dose was unchanged.
Spremljeno u:
| Izdano u: | BMJ Case Rep |
|---|---|
| Glavni autori: | , , |
| Format: | Artigo |
| Jezik: | Inglês |
| Izdano: |
BMJ Publishing Group
2021
|
| Teme: | |
| Online pristup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC8323353/ https://ncbi.nlm.nih.gov/pubmed/34326107 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1136/bcr-2020-240078 |
| Oznake: |
Dodaj oznaku
Bez oznaka, Budi prvi tko označuje ovaj zapis!
|